OTHER × Observational × Waldenstrom Macroglobulinemia × Clear all Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Active not recruiting
656 enrolled
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Recruiting
100 enrolled
PRAME
Recruiting
1,000 enrolled
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Recruiting
10,000 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.
Active not recruiting
212 enrolled
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Completed
146 enrolled
Watch and Wait or Worry and Wait in Indolent Lymphoma
Enrolling by invitation
250 enrolled
FIL_BIOWM
Completed
300 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process
Recruiting
90 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
Recruiting
200 enrolled
HMvax-Regist
Withdrawn
OCTA
Completed
20 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
DVR-Lym-Nim
Unknown
400 enrolled
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
Completed
10 enrolled 3 charts
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
MALYZOMA-II
Unknown
420 enrolled
GEN-HEMO-INF
Not yet recruiting
30 enrolled
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Completed
9 enrolled 4 charts
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Completed
41 enrolled
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Completed
17 enrolled
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Completed
36 enrolled
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Withdrawn
Studying Fentanyl in Patients With Cancer
Terminated
2 enrolled
Quality of Life in Younger Leukemia and Lymphoma Survivors
Completed
48 enrolled